691 related articles for article (PubMed ID: 7487087)
1. Roles of histidine-194, aspartate-163, and a glycine-rich sequence of NAD(P)H:quinone oxidoreductase in the interaction with nicotinamide coenzymes.
Cui K; Ma Q; Lu AY; Yang CS
Arch Biochem Biophys; 1995 Nov; 323(2):265-73. PubMed ID: 7487087
[TBL] [Abstract][Full Text] [Related]
2. Identification of a glycine-rich sequence as an NAD(P)H-binding site and tyrosine 128 as a dicumarol-binding site in rat liver NAD(P)H:quinone oxidoreductase by site-directed mutagenesis.
Ma Q; Cui K; Xiao F; Lu AY; Yang CS
J Biol Chem; 1992 Nov; 267(31):22298-304. PubMed ID: 1385397
[TBL] [Abstract][Full Text] [Related]
3. The role of NAD(P)H:quinone oxidoreductase in quinone-mediated p21 induction in human colon carcinoma cells.
Qiu XB; Cadenas E
Arch Biochem Biophys; 1997 Oct; 346(2):241-51. PubMed ID: 9343371
[TBL] [Abstract][Full Text] [Related]
4. Engineering and characterization of a NADPH-utilizing cytochrome b5 reductase.
Marohnic CC; Bewley MC; Barber MJ
Biochemistry; 2003 Sep; 42(38):11170-82. PubMed ID: 14503867
[TBL] [Abstract][Full Text] [Related]
5. Subunit functional studies of NAD(P)H:quinone oxidoreductase with a heterodimer approach.
Cui K; Lu AY; Yang CS
Proc Natl Acad Sci U S A; 1995 Feb; 92(4):1043-7. PubMed ID: 7862630
[TBL] [Abstract][Full Text] [Related]
6. Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase.
Wu K; Knox R; Sun XZ; Joseph P; Jaiswal AK; Zhang D; Deng PS; Chen S
Arch Biochem Biophys; 1997 Nov; 347(2):221-8. PubMed ID: 9367528
[TBL] [Abstract][Full Text] [Related]
7. p-nitrosophenol reduction by liver cytosol from ADH-positive and -negative deermice (Peromyscus maniculatus).
Dudley BF; Winston GW
Arch Biochem Biophys; 1995 Feb; 316(2):879-85. PubMed ID: 7532387
[TBL] [Abstract][Full Text] [Related]
8. Role of Ser457 of NADPH-cytochrome P450 oxidoreductase in catalysis and control of FAD oxidation-reduction potential.
Shen AL; Kasper CB
Biochemistry; 1996 Jul; 35(29):9451-9. PubMed ID: 8755724
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of NAD(P)H:quinone acceptor oxidoreductase by flavones: a structure-activity study.
Chen S; Hwang J; Deng PS
Arch Biochem Biophys; 1993 Apr; 302(1):72-7. PubMed ID: 8470908
[TBL] [Abstract][Full Text] [Related]
10. Site-directed mutagenesis of charged and potentially proton-carrying residues in the beta subunit of the proton-translocating nicotinamide nucleotide transhydrogenase from Escherichia coli. Characterization of the beta H91, beta D392, and beta K424 mutants.
Hu X; Zhang J; Fjellström O; Bizouarn T; Rydström J
Biochemistry; 1999 Feb; 38(5):1652-8. PubMed ID: 9931033
[TBL] [Abstract][Full Text] [Related]
11. Catalytic properties of NAD(P)H:quinone acceptor oxidoreductase: study involving mouse, rat, human, and mouse-rat chimeric enzymes.
Chen S; Knox R; Lewis AD; Friedlos F; Workman P; Deng PS; Fung M; Ebenstein D; Wu K; Tsai TM
Mol Pharmacol; 1995 May; 47(5):934-9. PubMed ID: 7746280
[TBL] [Abstract][Full Text] [Related]
12. Role of the His57-Glu214 ionic couple located in the active site of Mycobacterium tuberculosis FprA.
Pennati A; Razeto A; de Rosa M; Pandini V; Vanoni MA; Mattevi A; Coda A; Aliverti A; Zanetti G
Biochemistry; 2006 Jul; 45(29):8712-20. PubMed ID: 16846214
[TBL] [Abstract][Full Text] [Related]
13. Coenzyme site-directed mutants of photosynthetic A4-GAPDH show selectively reduced NADPH-dependent catalysis, similar to regulatory AB-GAPDH inhibited by oxidized thioredoxin.
Sparla F; Fermani S; Falini G; Zaffagnini M; Ripamonti A; Sabatino P; Pupillo P; Trost P
J Mol Biol; 2004 Jul; 340(5):1025-37. PubMed ID: 15236965
[TBL] [Abstract][Full Text] [Related]
14. Porcine recombinant dihydropyrimidine dehydrogenase: comparison of the spectroscopic and catalytic properties of the wild-type and C671A mutant enzymes.
Rosenbaum K; Jahnke K; Curti B; Hagen WR; Schnackerz KD; Vanoni MA
Biochemistry; 1998 Dec; 37(50):17598-609. PubMed ID: 9860876
[TBL] [Abstract][Full Text] [Related]
15. Functional interactions in cytochrome P450BM3: flavin semiquinone intermediates, role of NADP(H), and mechanism of electron transfer by the flavoprotein domain.
Murataliev MB; Klein M; Fulco A; Feyereisen R
Biochemistry; 1997 Jul; 36(27):8401-12. PubMed ID: 9204888
[TBL] [Abstract][Full Text] [Related]
16. Mutagenesis of Glycine 179 modulates both catalytic efficiency and reduced pyridine nucleotide specificity in cytochrome b5 reductase.
Roma GW; Crowley LJ; Davis CA; Barber MJ
Biochemistry; 2005 Oct; 44(41):13467-76. PubMed ID: 16216070
[TBL] [Abstract][Full Text] [Related]
17. Heterologous expression of an endogenous rat cytochrome b(5)/cytochrome b(5) reductase fusion protein: identification of histidines 62 and 85 as the heme axial ligands.
Davis CA; Dhawan IK; Johnson MK; Barber MJ
Arch Biochem Biophys; 2002 Apr; 400(1):63-75. PubMed ID: 11913972
[TBL] [Abstract][Full Text] [Related]
18. Retention of NADPH-linked quinone reductase activity in an aldo-keto reductase following mutation of the catalytic tyrosine.
Schlegel BP; Ratnam K; Penning TM
Biochemistry; 1998 Aug; 37(31):11003-11. PubMed ID: 9692994
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of a new type of NADPH-dependent quinone oxidoreductase (QOR2) from Escherichia coli.
Kim IK; Yim HS; Kim MK; Kim DW; Kim YM; Cha SS; Kang SO
J Mol Biol; 2008 May; 379(2):372-84. PubMed ID: 18455185
[TBL] [Abstract][Full Text] [Related]
20. A site-directed mutagenesis study at Lys-113 of NAD(P)H:quinone-acceptor oxidoreductase: an involvement of Lys-113 in the binding of the flavin adenine dinucleotide prosthetic group.
Tedeschi G; Deng PS; Chen HH; Forrest GL; Massey V; Chen S
Arch Biochem Biophys; 1995 Aug; 321(1):76-82. PubMed ID: 7639539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
